Clinical Trials Logo

Right Heart Dysfunction clinical trials

View clinical trials related to Right Heart Dysfunction.

Filter by:
  • None
  • Page 1

NCT ID: NCT04555161 Recruiting - Clinical trials for Pulmonary Hypertension

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

ASPIRE PH
Start date: March 15, 2021
Phase: N/A
Study type: Interventional

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.

NCT ID: NCT04467242 Recruiting - COPD Clinical Trials

Right Ventricular Diastolic Dysfunction

RVDD
Start date: July 20, 2020
Phase:
Study type: Observational

Heart-lung interactions remain misunderstood whereas pulmonary and cardiac pathologies are very commonly associated. Emphysema by increasing intrathoracic pressure appears to affect cardiac function. Interestingly, previous studies have shown a link between the telediastolic volume of the right ventricle (measured by RMI) and the intensity of emphysema. Our hypothesis is that the emphysema by increasing intrathoracic pressure leads to or accentuates right cardiac diastolic dysfunction by decreasing compliance and cardiac preload. To verify this hypothesis the investigators will perform KT loop procedures in order to acquire intracardiac pressure/volume curves before and after lung volume reduction. The pressure/volume curves allow the analysis of systolic and diastolic function, cardiac contractility and loading conditions.

NCT ID: NCT03649854 Completed - Clinical trials for Right Heart Dysfunction

Measurement of Tricuspid AnnularPlane Systolic Excursion in Transesophageal Echocardiography

TAPSE
Start date: August 15, 2014
Phase:
Study type: Observational

The aim of this study is to measure TAPSE in TEE using two deep transgastric views. This is a prospective comparative diagnostic study where 21 CABG patients who are enrolled for the study will be studied during the intraoperative period. The choice of general anaesthesia, hemodynamic management will be at the discretion of the anaesthesiologist in charge of the patient. The monitoring technique is standard as per any cardiac surgery with cardiopulmonary bypass. After induction of anaesthesia, TEE probe will be inserted by the PI or the Co-Investigator and the required TEE standard views and deep TG view of the right heart at zero degree and Deep TG view at 100-150 degrees will be acquired TAPSE will be measured in both the views using Mmode. The measurement will be done as follows: After acquiring the deep TG views the M mode cursor is aligned with the longitudinal motion the lateral tricuspid annulus. Once the Mmode picks up a good signal, 3 cycles are chosen and measured using calipers, and an average reading is taken. TAPSE will be used to evaluate the right heart function during the intraoperative period so that the patients with deteriorating right heart function can be identified and treatment started early. The potential benefits include the simplicity and reproducibility of the technique.